134 related articles for article (PubMed ID: 2530796)
1. The pharmacokinetics of paroxetine in the elderly.
Bayer AJ; Roberts NA; Allen EA; Horan M; Routledge PA; Swift CG; Byrne MM; Clarkson A; Zussman BD
Acta Psychiatr Scand Suppl; 1989; 350():85-6. PubMed ID: 2530796
[No Abstract] [Full Text] [Related]
2. The pharmacokinetics of paroxetine in elderly depressed patients.
Ghose K
Acta Psychiatr Scand Suppl; 1989; 350():87-8. PubMed ID: 2530797
[No Abstract] [Full Text] [Related]
3. The pharmacokinetics of paroxetine in patients with liver cirrhosis.
Krastev Z; Terziivanov D; Vlahov V; Maleev A; Greb WH; Eckl KM; Dierdorf HD; Wolf D
Acta Psychiatr Scand Suppl; 1989; 350():91-2. PubMed ID: 2530799
[No Abstract] [Full Text] [Related]
4. The pharmacokinetics of paroxetine in renal impairment.
Doyle GD; Laher M; Kelly JG; Byrne MM; Clarkson A; Zussman BD
Acta Psychiatr Scand Suppl; 1989; 350():89-90. PubMed ID: 2530798
[No Abstract] [Full Text] [Related]
5. Ability of charcoal to prevent absorption of paroxetine.
Greb WH; Buscher G; Dierdorf HD; von Schrader HW; Wolf D
Acta Psychiatr Scand Suppl; 1989; 350():156-7. PubMed ID: 2530777
[No Abstract] [Full Text] [Related]
6. Absorption of paroxetine under various dietary conditions and following antacid intake.
Greb WH; Brett MA; Buscher G; Dierdorf HD; von Schrader HW; Wolf D; Mellows G; Zussman BD
Acta Psychiatr Scand Suppl; 1989; 350():99-101. PubMed ID: 2530802
[No Abstract] [Full Text] [Related]
7. The clinical pharmacology of paroxetine in healthy subjects.
Raptopoulos P; McClelland GR; Jackson D
Acta Psychiatr Scand Suppl; 1989; 350():46-8. PubMed ID: 2530788
[No Abstract] [Full Text] [Related]
8. A pharmacokinetic dose titration study in adult and elderly depressed patients.
Hebenstreit GF; Fellerer K; Zöchling R; Zentz A; Dunbar GC
Acta Psychiatr Scand Suppl; 1989; 350():81-4. PubMed ID: 2530795
[No Abstract] [Full Text] [Related]
9. The effect of liver enzyme inhibition by cimetidine and enzyme induction by phenobarbitone on the pharmacokinetics of paroxetine.
Greb WH; Buscher G; Dierdorf HD; Köster FE; Wolf D; Mellows G
Acta Psychiatr Scand Suppl; 1989; 350():95-8. PubMed ID: 2530801
[No Abstract] [Full Text] [Related]
10. Evaluation of the potential for interactions of paroxetine with diazepam, cimetidine, warfarin, and digoxin.
Bannister SJ; Houser VP; Hulse JD; Kisicki JC; Rasmussen JG
Acta Psychiatr Scand Suppl; 1989; 350():102-6. PubMed ID: 2530759
[No Abstract] [Full Text] [Related]
11. Paroxetine plasma levels: lack of correlation with efficacy or adverse events.
Tasker TC; Kaye CM; Zussman BD; Link CG
Acta Psychiatr Scand Suppl; 1989; 350():152-5. PubMed ID: 2530776
[No Abstract] [Full Text] [Related]
12. Metabolic pathway of paroxetine in animals and man and the comparative pharmacological properties of its metabolites.
Haddock RE; Johnson AM; Langley PF; Nelson DR; Pope JA; Thomas DR; Woods FR
Acta Psychiatr Scand Suppl; 1989; 350():24-6. PubMed ID: 2530779
[No Abstract] [Full Text] [Related]
13. Regional distribution of serotonergic pre- and postsynaptic markers in human brain.
Laruelle M; Maloteaux JM
Acta Psychiatr Scand Suppl; 1989; 350():56-9. PubMed ID: 2530792
[No Abstract] [Full Text] [Related]
14. A review of the metabolism and pharmacokinetics of paroxetine in man.
Kaye CM; Haddock RE; Langley PF; Mellows G; Tasker TC; Zussman BD; Greb WH
Acta Psychiatr Scand Suppl; 1989; 350():60-75. PubMed ID: 2530793
[TBL] [Abstract][Full Text] [Related]
15. Paroxetine: pharmacokinetic and antidepressant effect in the elderly.
Lundmark J; Scheel Thomsen I; Fjord-Larsen T; Manniche PM; Mengel H; Møller-Nielsen EM; Pauser H; Wålinder J
Acta Psychiatr Scand Suppl; 1989; 350():76-80. PubMed ID: 2530794
[TBL] [Abstract][Full Text] [Related]
16. Relationship between parameters of serotonin transport and antidepressant plasma levels or therapeutic response in depressive patients treated with paroxetine and amitriptyline.
Kuhs H; Schlake HP; Rolf LH; Rudolf GA
Acta Psychiatr Scand; 1992 May; 85(5):364-9. PubMed ID: 1534961
[TBL] [Abstract][Full Text] [Related]
17. Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements.
Nielsen OA; Morsing I; Petersen JS; Larsen T; Møller SE; Manniche PM; Skausig OB
Acta Psychiatr Scand; 1991 Sep; 84(3):233-41. PubMed ID: 1835251
[TBL] [Abstract][Full Text] [Related]
18. Platelet 3H-paroxetine binding in depressed patients.
D'haenen H; De Waele M; Leysen JE
Psychiatry Res; 1988 Oct; 26(1):11-7. PubMed ID: 2976947
[TBL] [Abstract][Full Text] [Related]
19. Platelet 3H-imipramine and 3H-paroxetine binding during treatment with psychoactive drugs.
Mellerup ET; Dam H; Lauritzen L; Plenge P
Biol Psychiatry; 1991 Nov; 30(10):1056-8. PubMed ID: 1836743
[No Abstract] [Full Text] [Related]
20. Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
Dechant KL; Clissold SP
Drugs; 1991 Feb; 41(2):225-53. PubMed ID: 1709852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
